2021
DOI: 10.1017/s0033291720004985
|View full text |Cite
|
Sign up to set email alerts
|

The effect of sertraline on emotional processing: secondary analyses of the PANDA randomised controlled trial

Abstract: Background According to the cognitive neuropsychological model, antidepressants reduce symptoms of depression and anxiety by increasing positive relative to negative information processing. Most studies of whether antidepressants alter emotional processing use small samples of healthy individuals, which lead to low statistical power and selection bias and are difficult to generalise to clinical practice. We tested whether the selective serotonin reuptake inhibitor (SSRI) sertraline altered recall of posit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2
1

Relationship

2
6

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 36 publications
1
10
0
Order By: Relevance
“…A small number of studies have been conducted in primary care, with mixed findings. In a large scale RCT there was no evidence of a difference in recall of emotional words in primary care patients administered sertraline versus placebo over 6 weeks (Ahmed et al, 2021). However, supportive of the cognitive neuropsychological theory, in a prospective cohort study of patients treated with citalopram or reboxetine an increase in the recognition of positive facial emotions between baseline and two week follow-up was found to correlate with a reduction in mood by six weeks (Tranter et al, 2009).…”
Section: Introductionmentioning
confidence: 99%
“…A small number of studies have been conducted in primary care, with mixed findings. In a large scale RCT there was no evidence of a difference in recall of emotional words in primary care patients administered sertraline versus placebo over 6 weeks (Ahmed et al, 2021). However, supportive of the cognitive neuropsychological theory, in a prospective cohort study of patients treated with citalopram or reboxetine an increase in the recognition of positive facial emotions between baseline and two week follow-up was found to correlate with a reduction in mood by six weeks (Tranter et al, 2009).…”
Section: Introductionmentioning
confidence: 99%
“…Another possible reason may be a product of the emotional stimuli presented as part of the mEFT. Evidence suggests that emotional recognition tasks that employ facial stimuli, as used by Ahmed et al (2021), may be particularly sensitive to changes in emotional processing compared to that of the mEFT, which primarily presents situational stimuli. This interpretation is consistent with other findings that did not suggest an effect of linguistic stimuli (Browning et al, 2019;Ahmed et al, 2021) on emotional processing, stimuli which are thought to have a lower emotional impact relative to pictorial stimuli (Lees et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
“…Evidence suggests that emotional recognition tasks that employ facial stimuli, as used by Ahmed et al (2021), may be particularly sensitive to changes in emotional processing compared to that of the mEFT, which primarily presents situational stimuli. This interpretation is consistent with other findings that did not suggest an effect of linguistic stimuli (Browning et al, 2019;Ahmed et al, 2021) on emotional processing, stimuli which are thought to have a lower emotional impact relative to pictorial stimuli (Lees et al, 2005). While such illustrations have been described as being less emotionally salient compared to the real-life pictures, presented in our task (Okon-Singer et al, 2013), it is likely that facial stimuli may uniquely stimulate specific brain regions (Britton et al, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…Roiser et al 10,11 , Harmer 12 , Guitart-Masip et al 13 , Geurts et al 14 , Michely et al 15,16 , Lan and Browning 9 ). However, there is little evidence tying these experimental effects of SSRIs on cognition to improvement in symptoms in clinical settings as only a few randomized clinical trials (RCTs) have evaluated candidate mechanisms to explain treatment effects 17,18,19 . Evaluations in the context of RCTs comparing SSRIs and placebo provide a strong test of whether specific cognitive or learning processes are the mechanisms through which SSRIs alleviate symptoms of anxiety and depression.…”
Section: Introductionmentioning
confidence: 99%